These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1229 related articles for article (PubMed ID: 19334039)

  • 41. [Radiation associated leukemia and myelodysplastic syndrome].
    Kimura A
    Nihon Rinsho; 2012 Mar; 70(3):431-5. PubMed ID: 22514921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
    Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
    Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis.
    Rae DT; Hocum JD; Bii V; Deeg HJ; Trobridge GD
    Oncotarget; 2015 Oct; 6(31):30664-74. PubMed ID: 26384344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
    Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
    Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The molecular pathogenesis of acute myeloid leukemia.
    Steffen B; Müller-Tidow C; Schwäble J; Berdel WE; Serve H
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):195-221. PubMed ID: 16236521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
    Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F
    Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
    Tsai SC; Shih LY; Liang ST; Huang YJ; Kuo MC; Huang CF; Shih YS; Lin TH; Chiu MC; Liang DC
    Clin Cancer Res; 2015 Aug; 21(15):3541-51. PubMed ID: 25840971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
    Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel variant isoform of G-CSF receptor involved in induction of proliferation of FDCP-2 cells: relevance to the pathogenesis of myelodysplastic syndrome.
    Awaya N; Uchida H; Miyakawa Y; Kinjo K; Matsushita H; Nakajima H; Ikeda Y; Kizaki M
    J Cell Physiol; 2002 Jun; 191(3):327-35. PubMed ID: 12012328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
    Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Molecular mechanisms in myeloproliferative diseases and myelodysplastic syndromes].
    Harada H; Harada Y; Kimura A
    Nihon Rinsho; 2009 Oct; 67(10):1901-5. PubMed ID: 19860187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of Runx1/AML1 and Evi-1 in the regulation of hematopoietic stem cells.
    Kumano K; Kurokawa M
    J Cell Physiol; 2010 Feb; 222(2):282-5. PubMed ID: 19847803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetics of therapy-related myelodysplasia and acute myeloid leukemia.
    Pedersen-Bjergaard J; Andersen MK; Andersen MT; Christiansen DH
    Leukemia; 2008 Feb; 22(2):240-8. PubMed ID: 18200041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of RUNX1/AML1 as a classical tumor suppressor gene.
    Silva FP; Morolli B; Storlazzi CT; Anelli L; Wessels H; Bezrookove V; Kluin-Nelemans HC; Giphart-Gassler M
    Oncogene; 2003 Jan; 22(4):538-47. PubMed ID: 12555067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice.
    Yamashita N; Osato M; Huang L; Yanagida M; Kogan SC; Iwasaki M; Nakamura T; Shigesada K; Asou N; Ito Y
    Br J Haematol; 2005 Nov; 131(4):495-507. PubMed ID: 16281942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
    Kasashima K; Sakota E; Kozu T
    Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
    Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
    Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
    J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult.
    Motoda L; Osato M; Yamashita N; Jacob B; Chen LQ; Yanagida M; Ida H; Wee HJ; Sun AX; Taniuchi I; Littman D; Ito Y
    Stem Cells; 2007 Dec; 25(12):2976-86. PubMed ID: 17823240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.